March 13th, 2026

Researchers identify a key mechanism that promotes colorectal cancer metastasis

The absence of a protein, the kinase IKKα, enables tumor cells to cluster and survive during dissemination. The findings, published in Nature Communications, open the door to new prognostic markers and potential therapeutic strategies. Targeting tumor cell adhesion impairs their ability to migrate and form metastases. The study was conducted using a preclinical mouse model.

Read more sobre "Researchers identify a key mechanism that promotes colorectal cancer metastasis"

March 5th, 2026

Reduced working hours benefit health, but may increase gender differences

According to a study by the Hospital del Mar Research Institute, Pompeu Fabra University, Sant Joan de Deu Research Institute and Sant Joan de Déu Health Park, working fewer hours while maintaining the same salary has a positive effect on physical and mental health and work-life balance. However, it also finds that, in the experiences evaluated, the measure may increase the unequal distribution of roles between women and men. It notes that women devote more time to caregiving and domestic work, while men spend more on leisure. The researchers conducted a systematic review of the scientific evidence surrounding this type of measure. They highlight that any initiative in this field must also include an analysis of other working conditions that may have an impact on health.

Read more sobre "Reduced working hours benefit health, but may increase gender differences"

February, 18th, 2026

A large-scale study analyzes the evolution of the most common cancers in Europe

A European macro-study, published in The Lancet Regional Health-Europe, analyzes disease trajectories, associated conditions, and survival among people with cancer. Hospital del Mar and the Hospital del Mar Research Institute took part in the research, which evaluates real-world clinical data from a cohort of more than 1.7 million patients from eight European countries. The most frequent cancers in Europe are breast, prostate, colorectal, and lung cancer. The highest survival rates a re seen in breast and prostate cancer, while pancreatic cancer has the poorest prognosis. Databases from Spain, Estonia, and Switzerland show the best survival rates.

Read more sobre "A large-scale study analyzes the evolution of the most common cancers in Europe"

II Jornadas OsteoReuma

27 de marzo de 2026

Barcelona HIP meeting 2026

27 d'abril de 2026

27 Congreso SECCA

20 de mayo de 2026